Zoradi Mark

Director Zoradi Mark sold 150,000 CNK shares (34% of holdings) for $4.4M as stock trades well below 52-week highs.

Zoradi Mark, a Cinemark director, sold approximately one-third of his stake in a single transaction, reducing his holdings substantially. The timing is notable: his two prior sales at this company were both well-timed, with the stock declining in both the near and longer term after each exit, suggesting he has a track record of selling before downturns at Cinemark specifically. The current sale occurs as the stock trades meaningfully below its 52-week high, and the company, while still profitable and growing revenue, posted a net loss in the most recent quarter—a shift from profitability. This is the third open-market sale Mark has made at Cinemark in the past three years, showing a consistent pattern of reducing rather than building his position in the company.

Director Zoradi Mark sold 85,229 shares at $32.38 on 2024-11-21, reducing stake by 7.9% despite stock down 33.5% from 52-week high.

Director Zoradi Mark executed 2 separate sales totaling 87,229 shares for $2,792,055.02 during this filing period, with the largest transaction—85,229 shares at $32.38 on 2024-11-21—reducing his holdings from 473,837 to 436,608 shares. The November sale occurred when the stock traded near the lower end of its 52-week range ($21.93–$33.77) and has declined 23.9% in the 30 days following the transaction. Critically, this mirrors a prior trading pattern: the same insider's single earlier sale at CNK (also on 2024-11-21 per SAME-TICKER HISTORY) showed a 90d return of -11.8%, meaning the stock fell after he sold—a well-timed exit. However, the sell occurred after the stock had already sustained substantial damage: at the time of sale the price was -33.5% from the 52-week high, suggesting the move may be reactive to price deterioration rather than prescient. The scale of the disposition—87.2K shares representing a net reduction of 7.9% of holdings—is material and warrants examination of whether company fundamentals or governance developments prompted the reduction.

Cinemark director Mark Zoradi sold 85,229 shares (85.2K) at $32.38 on 2024-11-21 for $2.8M, reducing stake by 16.1%

Director Mark Zoradi executed a sale of 85,229 shares (85.2K) at $32.38 on 2024-11-21, reducing his holdings from 529.2K to 444.0K shares and realizing $2.8M in proceeds. The transaction occurred near the 52-week high of $33.45, with the stock at current price of $32.63 showing +15.1% over 30 days and +17.4% over 90 days. Cinemark's fundamentals remain solid with annual revenue growth of +24.9%, net income of $187.8M, and a low P/E of 6.02, suggesting the company is not in distress. The sale represents a meaningful but not complete exit from his position, removing 16.1% of his pre-transaction holdings at a price point consistent with recent strength in the stock. This is the second transaction of record for this insider, with limited history available to assess any broader trading pattern at this ticker.